Boston Scientific Corp Stock Last Dividend Paid

BSX Stock

USD 72.91 3.92 5.68%

Boston Scientific Corp fundamentals help investors to digest information that contributes to Boston Scientific's financial success or failures. It also enables traders to predict the movement of Boston Stock. The fundamental analysis module provides a way to measure Boston Scientific's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Boston Scientific stock.

Short Long Term Debt Total Total Assets

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Boston Scientific Corp Company Last Dividend Paid Analysis

Boston Scientific's Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.

Last Dividend

Last Profit Distribution Amount

Total Shares

More About Last Dividend Paid | All Equity Analysis

Boston Last Dividend Paid Driver Correlations

Understanding the fundamental principles of building solid financial models for Boston Scientific is extremely important. It helps to project a fair market value of Boston Stock properly, considering its historical fundamentals such as Last Dividend Paid. Since Boston Scientific's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Boston Scientific's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Boston Scientific's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Short Term Investments	Common Stock	Long Term Debt	Good Will	Treasury Stock	Property Plant Equipment	Current Deferred Revenue	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Cash And Equivalents	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.97	0.94	0.5	0.89	0.94	0.77	0.83	0.1	0.59	0.78	0.66	0.87	0.9	-0.75	0.83	-0.45	0.77	0.69	0.79	-0.59	0.66	-0.03	0.66	0.87	0.8	0.7
Total Stockholder Equity	0.97		0.87	0.65	0.9	0.88	0.65	0.78	0.01	0.43	0.77	0.53	0.82	0.89	-0.65	0.81	-0.37	0.85	0.74	0.83	-0.49	0.6	-0.1	0.7	0.91	0.84	0.78
Net Debt	0.94	0.87		0.41	0.83	0.93	0.82	0.79	0.32	0.64	0.84	0.65	0.87	0.82	-0.78	0.77	-0.55	0.64	0.69	0.69	-0.66	0.74	0.17	0.51	0.82	0.71	0.56
Retained Earnings	0.5	0.65	0.41		0.59	0.3	0.05	0.3	-0.13	-0.31	0.57	-0.23	0.4	0.46	-0.12	0.4	-0.18	0.71	0.78	0.66	-0.07	0.36	-0.16	0.6	0.79	0.72	0.69
Accounts Payable	0.89	0.9	0.83	0.59		0.89	0.58	0.7	0.12	0.3	0.85	0.52	0.72	0.79	-0.74	0.78	-0.52	0.82	0.69	0.85	-0.67	0.58	-0.02	0.64	0.86	0.77	0.8
Net Receivables	0.94	0.88	0.93	0.3	0.89		0.76	0.73	0.27	0.67	0.77	0.75	0.76	0.83	-0.76	0.8	-0.46	0.67	0.52	0.7	-0.7	0.57	0.14	0.43	0.73	0.6	0.64
Total Liab	0.77	0.65	0.82	0.05	0.58	0.76		0.92	0.25	0.84	0.59	0.85	0.9	0.83	-0.78	0.82	-0.56	0.35	0.55	0.58	-0.58	0.62	0.09	0.48	0.6	0.58	0.29
Total Current Assets	0.83	0.78	0.79	0.3	0.7	0.73	0.92		0.1	0.62	0.68	0.75	0.93	0.89	-0.82	0.89	-0.54	0.59	0.72	0.8	-0.58	0.71	-0.06	0.75	0.77	0.81	0.53
Short Term Debt	0.1	0.01	0.32	-0.13	0.12	0.27	0.25	0.1		0.28	0.51	0.13	-0.01	0.08	-0.17	0.09	-0.23	-0.18	-0.11	-0.03	-0.28	0.22	0.97	-0.24	0.02	-0.12	-0.1
Intangible Assets	0.59	0.43	0.64	-0.31	0.3	0.67	0.84	0.62	0.28		0.27	0.86	0.61	0.61	-0.52	0.55	-0.29	0.05	0.1	0.18	-0.38	0.3	0.19	0.07	0.22	0.16	0.01
Short Term Investments	0.78	0.77	0.84	0.57	0.85	0.77	0.59	0.68	0.51	0.27		0.37	0.66	0.68	-0.68	0.66	-0.62	0.66	0.67	0.73	-0.66	0.77	0.38	0.58	0.81	0.74	0.61
Common Stock	0.66	0.53	0.65	-0.23	0.52	0.75	0.85	0.75	0.13	0.86	0.37		0.68	0.7	-0.73	0.72	-0.45	0.3	0.25	0.47	-0.63	0.42	-0.02	0.28	0.34	0.33	0.3
Long Term Debt	0.87	0.82	0.87	0.4	0.72	0.76	0.9	0.93	-0.01	0.61	0.66	0.68		0.88	-0.79	0.85	-0.58	0.61	0.83	0.76	-0.57	0.73	-0.17	0.72	0.84	0.83	0.51
Good Will	0.9	0.89	0.82	0.46	0.79	0.83	0.83	0.89	0.08	0.61	0.68	0.7	0.88		-0.64	0.95	-0.42	0.66	0.72	0.82	-0.47	0.54	-0.04	0.63	0.81	0.75	0.64
Treasury Stock	-0.75	-0.65	-0.78	-0.12	-0.74	-0.76	-0.78	-0.82	-0.17	-0.52	-0.68	-0.73	-0.79	-0.64		-0.69	0.58	-0.55	-0.54	-0.66	0.84	-0.72	0.03	-0.61	-0.65	-0.68	-0.45
Property Plant Equipment	0.83	0.81	0.77	0.4	0.78	0.8	0.82	0.89	0.09	0.55	0.66	0.72	0.85	0.95	-0.69		-0.45	0.68	0.72	0.87	-0.54	0.5	-0.04	0.56	0.79	0.72	0.68
Current Deferred Revenue	-0.45	-0.37	-0.55	-0.18	-0.52	-0.46	-0.56	-0.54	-0.23	-0.29	-0.62	-0.45	-0.58	-0.42	0.58	-0.45		-0.27	-0.48	-0.4	0.71	-0.64	-0.11	-0.41	-0.47	-0.49	-0.17
Net Tangible Assets	0.77	0.85	0.64	0.71	0.82	0.67	0.35	0.59	-0.18	0.05	0.66	0.3	0.61	0.66	-0.55	0.68	-0.27		0.71	0.85	-0.45	0.57	-0.27	0.65	0.83	0.82	0.87
Long Term Debt Total	0.69	0.74	0.69	0.78	0.69	0.52	0.55	0.72	-0.11	0.1	0.67	0.25	0.83	0.72	-0.54	0.72	-0.48	0.71		0.85	-0.38	0.68	-0.24	0.76	0.92	0.89	0.68
Capital Surpluse	0.79	0.83	0.69	0.66	0.85	0.7	0.58	0.8	-0.03	0.18	0.73	0.47	0.76	0.82	-0.66	0.87	-0.4	0.85	0.85		-0.54	0.59	-0.16	0.76	0.89	0.86	0.91
Deferred Long Term Liab	-0.59	-0.49	-0.66	-0.07	-0.67	-0.7	-0.58	-0.58	-0.28	-0.38	-0.66	-0.63	-0.57	-0.47	0.84	-0.54	0.71	-0.45	-0.38	-0.54		-0.62	-0.13	-0.37	-0.49	-0.46	-0.41
Long Term Investments	0.66	0.6	0.74	0.36	0.58	0.57	0.62	0.71	0.22	0.3	0.77	0.42	0.73	0.54	-0.72	0.5	-0.64	0.57	0.68	0.59	-0.62		0.06	0.65	0.67	0.75	0.41
Short Long Term Debt	-0.03	-0.1	0.17	-0.16	-0.02	0.14	0.09	-0.06	0.97	0.19	0.38	-0.02	-0.17	-0.04	0.03	-0.04	-0.11	-0.27	-0.24	-0.16	-0.13	0.06		-0.36	-0.1	-0.25	-0.18
Cash And Equivalents	0.66	0.7	0.51	0.6	0.64	0.43	0.48	0.75	-0.24	0.07	0.58	0.28	0.72	0.63	-0.61	0.56	-0.41	0.65	0.76	0.76	-0.37	0.65	-0.36		0.78	0.92	0.6
Net Invested Capital	0.87	0.91	0.82	0.79	0.86	0.73	0.6	0.77	0.02	0.22	0.81	0.34	0.84	0.81	-0.65	0.79	-0.47	0.83	0.92	0.89	-0.49	0.67	-0.1	0.78		0.94	0.77
Net Working Capital	0.8	0.84	0.71	0.72	0.77	0.6	0.58	0.81	-0.12	0.16	0.74	0.33	0.83	0.75	-0.68	0.72	-0.49	0.82	0.89	0.86	-0.46	0.75	-0.25	0.92	0.94		0.69
Capital Stock	0.7	0.78	0.56	0.69	0.8	0.64	0.29	0.53	-0.1	0.01	0.61	0.3	0.51	0.64	-0.45	0.68	-0.17	0.87	0.68	0.91	-0.41	0.41	-0.18	0.6	0.77	0.69

Click cells to compare fundamentals

Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.

Competition

Predict Boston Scientific

Boston Additional Paid In Capital

Additional Paid In Capital

20.72 Billion

At this time, Boston Scientific's Additional Paid In Capital is fairly stable compared to the past year.

Based on the recorded statements, Boston Scientific Corp has a Last Dividend Paid of 0.0. This indicator is about the same for the Health Care Equipment & Supplies average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).

Did you try this?

Run Pair Correlation Now

Pair Correlation

Compare performance and examine fundamental relationship between any two equity instruments

All Next

Launch Module

Boston Scientific ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Boston Scientific's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Boston Scientific's managers, analysts, and investors.

Environment Score

Governance Score

Social Score

Boston Fundamentals

	Return On Equity	0.0858
	Return On Asset	0.0447
	Profit Margin	0.11 %
	Operating Margin	0.17 %
	Current Valuation	110.17 B
	Shares Outstanding	1.47 B
	Shares Owned By Insiders	0.19 %
	Shares Owned By Institutions	94.46 %
	Number Of Shares Shorted	12.43 M
	Price To Earning	107.05 X
	Price To Book	5.19 X
	Price To Sales	7.03 X
	Revenue	14.24 B
	Gross Profit	8.68 B
	EBITDA	3.62 B
	Net Income	1.59 B
	Cash And Equivalents	928 M
	Cash Per Share	0.24 X
	Total Debt	9.49 B
	Debt To Equity	0.51 %
	Current Ratio	1.45 X
	Book Value Per Share	13.15 X
	Cash Flow From Operations	2.5 B
	Short Ratio	2.01 X
	Earnings Per Share	1.07 X
	Price To Earnings To Growth	1.80 X
	Target Price	74.2
	Number Of Employees	48 K
	Beta	0.79
	Market Capitalization	101.41 B
	Total Asset	35.14 B
	Retained Earnings	819 M
	Working Capital	1.58 B
	Current Asset	1.21 B
	Current Liabilities	923 M
	Net Asset	35.14 B

About Boston Scientific Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Boston Scientific Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Boston Scientific using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Boston Scientific Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Pair Trading with Boston Scientific

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Boston Scientific position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Boston Scientific will appreciate offsetting losses from the drop in the long position's value.

Moving together with Boston Stock

0.69

HQY

HealthEquity Financial Report 3rd of June 2024

Pair Corr

Moving against Boston Stock

0.91	SINT	SINTX Technologies	Pair Corr
0.8	RSLS	ReShape Lifesciences	Pair Corr
0.74	BBLG	Bone Biologics Corp Financial Report 20th of May 2024	Pair Corr
0.73	HCAT	Health Catalyst Financial Report 14th of May 2024	Pair Corr
0.72	HSDT	Helius Medical Techn Financial Report 9th of May 2024	Pair Corr

The ability to find closely correlated positions to Boston Scientific could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Boston Scientific when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Boston Scientific - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Boston Scientific Corp to buy it.

The correlation of Boston Scientific is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Boston Scientific moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Boston Scientific Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Boston Scientific can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Boston Scientific Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Boston Scientific's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Boston Scientific Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Boston Scientific Corp Stock:

How To Invest In Boston

Details

Is Boston Stock a good investment?

Details

What is Boston Scientific's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Boston Scientific Piotroski F Score and Boston Scientific Altman Z Score analysis.

You can also try the Stocks Directory module to find actively traded stocks across global markets.

Complementary Tools for Boston Stock analysis

When running Boston Scientific's price analysis, check to measure Boston Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boston Scientific is operating at the current time. Most of Boston Scientific's value examination focuses on studying past and present price action to predict the probability of Boston Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boston Scientific's price. Additionally, you may evaluate how the addition of Boston Scientific to your portfolios can decrease your overall portfolio volatility.

	Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities
	Transaction History View history of all your transactions and understand their impact on performance
	Insider Screener Find insiders across different sectors to evaluate their impact on performance
	Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets
	Volatility Analysis Get historical volatility and risk analysis based on latest market data
	Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format
	Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
	Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios
	Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities

Is Boston Scientific's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Boston Scientific. If investors know Boston will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Boston Scientific listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

2.856

Earnings Share

1.07

Revenue Per Share

9.8

Quarterly Revenue Growth

0.149

Return On Assets

0.0447

The market value of Boston Scientific Corp is measured differently than its book value, which is the value of Boston that is recorded on the company's balance sheet. Investors also form their own opinion of Boston Scientific's value that differs from its market value or its book value, called intrinsic value, which is Boston Scientific's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Boston Scientific's market value can be influenced by many factors that don't directly affect Boston Scientific's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Boston Scientific's value and its price as these two are different measures arrived at by different means. Investors typically determine if Boston Scientific is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Boston Scientific's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Boston Scientific Corp Stock Last Dividend Paid

Boston Scientific Corp Company Last Dividend Paid Analysis

Last Dividend

Last Profit Distribution Amount

Total Shares

Boston Last Dividend Paid Driver Correlations

Boston Additional Paid In Capital

Additional Paid In Capital

20.72 Billion

Did you try this?

Run Pair Correlation Now

Pair Correlation

Boston Scientific ESG Sustainability

Boston Fundamentals

About Boston Scientific Fundamental Analysis

Pair Trading with Boston Scientific

Moving together with Boston Stock

Moving against Boston Stock

Complementary Tools for Boston Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY